01
In-Vitro Analysis
Initial molecular testing within our controlled laboratory environment to assess ingredient stability, cellular toxicity, and baseline bio-compatibility.
Clinical Trials & Efficacy.
The Evaluation Protocol
Our testing frameworks are designed to exceed standard cosmetic compliance, utilizing diverse participant pools across our clinical testing hubs in Kerala and the UAE to ensure global efficacy.
02
Longitudinal In-Vivo Studies
Extended 8-to-12-week clinical trials on human volunteers to measure cumulative barrier improvement, hydration retention, and cellular turnover.
03
Dermatological Vetting
Independent, double-blind evaluations conducted by board-certified dermatologists to confirm safety profiles across various skin phototypes and conditions.
The Results
Quantifying Skin Health
Our flagship Barrier Defense Matrix was subjected to a comprehensive 12-week independent clinical study involving 120 participants. The physiological markers measured included Transepidermal Water Loss (TEWL), lipid density, and erythema reduction.
Download Full Clinical Report (PDF)
40
%
Reduction in TEWL
Participants showed a significant decrease in water loss after 14 days of continued application.
92
%
Decreased Sensitivity
Subjective assessment noted improved resilience against environmental and physical stressors.
2.5
X
Lipid Density Increase
Instrumental measurement revealed fortified ceramide and lipid structures within the stratum corneum.